— Know what they know.
Not Investment Advice

CBDX OTC

Curative Biosciences, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -90.0% 5Y: -92.7%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 50 · $25789 mcap · 182M float · 0.0010% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.0001-0.0002
Volume600
Avg Volume1,860
Beta8.28
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMarcel Gamma
Employees6
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2004-08-26
801 Brickell Avenue
Miami, FL 33131
US
+1 561 247 1656
About Curative Biosciences, Inc.

Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. It intends to manufacture and market natural health products and operate in the medical cannabis industry. The company was formerly known as Amaize Beverage Corporation and changed its name to Curative Biosciences, Inc. in August 2017. Curative Biosciences, Inc. was founded in 2009 and is based in Miami, Florida.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms